Clinical Trials Browser

Phase 2 × rilotumumab × Sarcoma × Clear all

NCT01113398 2015-12-10

AMG 102 and Avastin for Recurrent Malignant Glioma

Phase 2 Completed

36 enrolled 9 charts

Glioblastoma, Glioma, Recurrence, Gliosarcoma